98%
921
2 minutes
20
Youth with parental substance use disorder (family-history positive [FH+]) are at an elevated risk for substance use problems, but not all FH+ youth experience this outcome. Frontostriatal brain networks involved in inhibitory control and reward responsivity underlie risk-taking behaviors, but the role of these networks in substance use heterogeneity among FH+ youth has not been examined. The present study examined resting state functional connectivity (RSFC) in frontostriatal networks in FH+ youth with and without risky substance use. Participants were 36 FH+ adolescents (mean age 14.96 years at the scan date; 36% female) from a longitudinal, community-based functional magnetic resonance imaging study enriched for parental alcohol use disorder. Groups were based on the absence (resilient) or presence (high-risk) of at least one occasion of any substance use by age 14 and also use of at least two different types of substances by the most recent substance use assessment (mean age 16.89 years). Bilateral masks of the dorsolateral prefrontal cortex (DLPFC) and the nucleus accumbens were used for seed-based RSFC due to the importance of these regions in executive control and salience networks, respectively. Compared with FH+/high-risk youth, FH+/resilient youth displayed greater connectivity between the left DLPFC seed and the left posterior cingulate cortex. No other brain regions showed significantly different RSFC between resilient and high-risk groups. FH+/resilient youth showed stronger synchrony between brain regions associated with cognitive control, particularly those associated with flexible adaptation of thoughts and behaviors. Although preliminary, the results of this study set the stage for a continued focus on risk-group heterogeneity to better identify neural markers of resilience against substance use problems in vulnerable populations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727473 | PMC |
http://dx.doi.org/10.1089/cap.2018.0169 | DOI Listing |
Nat Commun
September 2025
Institute of Neurosciences and Medicine, Brain & Behaviour (INM-7), Research Centre Juelich; Wilhelm-Johnen-Straße 1, Juelich, Germany.
Autism is a neurodevelopmental condition associated with altered resting-state brain function. An increased excitation-inhibition ratio is discussed as a pathomechanism but in-vivo evidence of disturbed neurotransmission underlying functional alterations remains scarce. We compare local resting-state brain activity and neurotransmitter co-localizations between autism (N = 405, N = 395) and neurotypical controls (N = 473, N = 474) in two independent cohorts and correlate them with excitation-inhibition changes induced by glutamatergic (ketamine) and GABAergic (midazolam) medication.
View Article and Find Full Text PDFShanghai Kou Qiang Yi Xue
June 2025
Hefei Stomatology Hospital and Anhui Medical University Hefei School of Stomatology. Hefei 230001, China. E-mail:
Purpose: To evaluate the clinical effect of a new fixed Twin-block on adolescent patients with skeletal ClassⅡ malocclusion.
Methods: Twenty-one patients aged 10-13 years with skeletal ClassⅡ malocclusion with mandibular retrusion were chosen for functional treatment using a new fixed Twin-block. Before and after treatment, panoramic and cephalometric films were taken, and the observation indexes were measured and recorded.
BMJ Open
August 2025
Magister of Information Systems, Postgraduate Faculty, Universitas Komputer Indonesia, Bandung, West Java, Indonesia
Objective: This study aimed to screen for hypertension in a vast Indonesian population using machine learning (ML) and 11 non-laboratory risk factors, validating the results through internal and external validations.
Setting And Participants: From the initial 1 782 365 participants aged 15 and above registered at the Integrated Counseling Post primary care centres across Indonesia from 2014 to 2017, incomplete data and outliers were excluded, and 268 210 participants were included in our analysis. The dataset was split deterministically into a dataset for training using 10-fold internal cross-validation of 204 315 participants and another dataset for external validation of 63 895 participants.
Diagn Pathol
August 2025
Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, 700 Children's Dr, Columbus, OH, 43205, USA.
Background: Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC) is an autosomal dominant tumor predisposition syndrome with germline fumarate hydratase (FH) pathogenic variants. We describe the unusual clinical presentation, morphologic, and immunohistochemical features of bilateral renal cell carcinoma (RCC) occurring in polycystic kidneys in a 15-year-old male with HLRCC.
Case Presentation: The patient was diagnosed with bilateral polycystic kidneys at 1-year old.
Background: Familial hypercholesterolaemia (FH) is a hereditary disorder characterised by elevated low-density lipoprotein cholesterol (LDL-C) levels, substantially increasing the risk of atherosclerotic cardiovascular disease. Proprotein convertase subtilisin/kexin type 9 (PCSK9) targeting therapies, including monoclonal antibodies and small interfering RNA (siRNA) agents, have emerged as effective lipid lowering therapies.
Objective: To assess the efficacy and safety of PCSK9-targeting therapy on lipid biomarkers and adverse events in patients with FH, compared with placebo on the background of standard lipid-lowering therapy.